DR. LAL PATHLABS LTD.
|
Market Cap.(`)
|
23191.69 Cr.
|
P/BV
|
11.59
|
Book Value (`)
|
239.45
|
|
52 Week High/Low ( ` )
|
3654/2201
|
FV/ML
|
10/1
|
P/E(X)
|
47.61
|
|
Book Closure
|
06/06/2025
|
EPS (`)
|
58.27
|
Div Yield (%)
|
0.87
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2461.40 | 2226.50 | 2016.64 | 2087.28 | 1581.18 |
| Other Operating Revenues | 0.00 | 0.14 | 0.24 | 0.13 | 0.08 |
| Total Operating Revenues | 2461.40 | 2226.64 | 2016.88 | 2087.41 | 1581.27 |
| | | | | | |
| Other Income | 93.40 | 69.17 | 41.72 | 52.55 | 51.33 |
| Total Revenue | 2554.80 | 2295.81 | 2058.60 | 2139.95 | 1632.60 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 481.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating And Direct Expenses | 0.00 | 451.42 | 447.15 | 502.25 | 397.26 |
| Employee Benefit Expenses | 482.40 | 424.57 | 376.52 | 364.94 | 273.70 |
| Finance Costs | 22.30 | 29.36 | 37.53 | 30.18 | 16.00 |
| Depreciation And Amortisation Expenses | 141.90 | 143.60 | 150.19 | 108.11 | 77.20 |
| Other Expenses | 802.00 | 741.41 | 703.37 | 659.50 | 474.03 |
| Total Expenses | 1930.10 | 1790.36 | 1714.77 | 1664.97 | 1238.19 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 624.70 | 505.45 | 343.83 | 474.98 | 394.41 |
| | | | | | |
| Profit/Loss Before Tax | 624.70 | 505.45 | 343.83 | 474.98 | 394.41 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 132.50 | 148.03 | 107.89 | 129.52 | 102.11 |
| Deferred Tax | 0.00 | -4.87 | -5.14 | -1.79 | -4.18 |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | -3.04 | 0.00 |
| Total Tax Expenses | 132.50 | 143.16 | 102.75 | 124.69 | 97.93 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 492.20 | 362.29 | 241.08 | 350.29 | 296.48 |
| | | | | | |
| Profit/Loss From Continuing Operations | 492.20 | 362.29 | 241.08 | 350.29 | 296.48 |
| | | | | | |
| Profit/Loss For The Period | 492.20 | 362.29 | 241.08 | 350.29 | 296.48 |
| | | | | | |
| Minority Interest | -5.10 | -4.56 | -2.23 | -5.46 | -4.86 |
| Consolidated Profit/Loss After MI And Associates | 487.10 | 357.74 | 238.85 | 344.83 | 291.62 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 58.48 | 43.05 | 28.82 | 41.70 | 35.33 |
| Diluted EPS (Rs.) | 58.40 | 42.98 | 28.74 | 41.70 | 35.25 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 199.48 | 99.43 | 115.71 | 99.11 |